European Psychiatry - Volume 41 - April 2017

94 / 916

S90 25th European Congress of Psychiatry / European Psychiatry 41S (2017) S69–S105
also have evidence-based studies that depression for example is an
independent risk factor of heart infarct onset. On the other hand,
we observe the somatization of clinical picture of mental disorders,
the increase of atypical forms manifesting through pain or other
somatic syndromes that leads to the increase of mental illnesses in
the primary care. The research of common pathways of mental and
somatic pathology should be the subject of further interdisciplinary
research programs. The other issue is the patient’s compliance that
plays in important role in the success of every kind of treatment.
Personality traits and status of mental health can influence ones
attitude to illness as well as motivation to therapy. We cannot
assess the population state of health without taking into consid-
eration the evaluation of mental status as well as such definitions
like subjective well being, life quality and stigmatization.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
Oral communications: Epidemiology and social
psychiatry; migration and mental health of
immigrants; forensic psychiatry; suicidology and
suicide prevention; prevention of mental
disorders and promotion of mental health
O060
Personality disorders and perinatal
psychiatry: Food for thoughts from
perinatal psychiatric department
experience
E. Di Giacomo ∗, F. Colmegna , M. Clerici
1 PhD program in Neuroscience–Doctorate School of the University of
Milano–Bicocca, Psychiatric Department–S. Gerardo Health Care
Trust–Italy, Milan, Italy
2 S. Gerardo Health Care Trust, Psychiatric Department, Monza, Italy
3 University of Milano Bicocca, School of Medicine and Surgery,
Milan, Italy
∗ Corresponding author.
Background Pregnancy and postpartum are sensitive unique
moments in women’s life. Perinatal psychiatry is focused on
depression and psychosis, but personality issues is often neglected
as well as risk factors for personality disorders instead of being
considered causative of onset or recrudescence of psychiatric
symptoms in perinatal.
Methods In total, 129 women were referred to perinatal psychi-
atric department during their pregnancy or postpartum in the last
three years. They were administered SCID II, Childhood Trauma
Questionnaire (CTQ), Beck Depression and Anxiety Inventories (BDI
and BAI), Edinburgh Postnatal Depression Scale (EPDS) and World
Health Organization Quality of Life (WHOQOL). Their interaction
with babies wasmonitored at birth and during followup. Children’s
behavioral development is under evaluation through structured
tests.
Results BDI and BAI scored moderate or severe in 31 and 27%
of women, EPDS was significant in 36%, while SCID II highlighted
24% of borderline, 17% narcissistic, 4% schizoid, 4% paranoid and 9%
obsessive/compulsive PD. Nineteen of themsuffered physical abuse
during childhood, 26 sexual abuse, 89 emotional neglect and only
15 out of 129 were negative to any kind of abuse during childhood.
Conclusion Personality disorders appears to influence maternal
adjustment to pregnancy and motherhood. Abuses suffered during
childhood confirm their role as potential risk factor in personality
issues which clearly express their effect in adaptation to change in
personal role and in emphatic interactions.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
O061
What do patients want? Correlates of
patient satisfaction and treatment
engagement
R. Gearing ∗ ebb
University of Houston, GCSW, Houston, USA
∗ Corresponding author.
Introduction Motivation and ability to engage with treatment
may deteriorate or falter if a patient is not satisfied with their
protocols or provider. Improving patient satisfaction may more
effectively strengthen treatment engagement.
Objectives 1) Determining what patients want from their
provider relationship; and 2) identifying means for a provider to
effectively assess and evaluate patient satisfaction in relation to
treatment engagement.
Methods A systematic review of published meta-analyses, sys-
tematic reviews, and literature reviews between 1996 and
2016 was conducted across three databases (Medline, PsycINFO,
CINAHL). Using variations of the search terms patient; satisfaction;
medication, medical and psychiatric treatment; and engage-
ment/adherence, a total of 1667 articles were identified. After
removing duplications, 1582 articles were independently screened
for eligibility (e.g. conceptual focus, methodological limitations)
by two research assistants, resulting in the final inclusion of 50
meta-analysis, systematic review, or literature review articles that
focused on predictors or barriers to patient satisfaction and/or pre-
dictors or barriers affecting engagement/adherence.
Results Barriers and predictors of patient satisfaction centered
on two fundamental domains:
– relationship with Provider (sub-factors: multicultural compe-
tence, shared decision making, communication skills, continuity of
care, empathy) and;
– outcomes (sub-factors: therapeutic outcome, patient expecta-
tions).
Eight treatment engagement/adherence barrier and predictor
domains were identified, specifically treatment regimens; ill-
ness beliefs, emotional/cognitive factors; financial and logistic;
social support; symptom/illness characteristics; demographics and
patient-provider relationship.
Conclusions Key findings highlight actions psychiatrists and
other clinical providers may consider in addressing barriers and
highlighting promoters to improve patient satisfaction and overall
engagement and adherence.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
O062
The efficacy of lurasidone on PANSS
subscales in adolescent patients with
schizophrenia: Results from a 6-week,
double-blind, placebo-controlled,
multicenter study
C. Correll , R. Goldman ∗, J. Cucchiaro , L. Deng , A. Loebel
1 Hofstra Northwell School of Medicine, Psychiatry and Molecular
Medicine, Hempstead, NY, USA
2 The Zucker Hillside Hospital, Department of Psychiatry, Glen Oaks,
NY, USA
3 Sunovion Pharmaceuticals Inc., Medical Affairs, Fort Lee, NJ, USA
4 Sunovion Pharmaceuticals Inc., Clinical Operations, Fort Lee, NJ, USA
5 Sunovion Pharmaceuticals Inc., Biostatistics, Fort Lee, NJ, USA